Identification of Arginine Deiminase Gene Therapy for Disordered Proteins
- 技术优势
- Decreases tau levels, Metabolizes arginine, Does not increase nitric oxide or polyamines
- 详细技术说明
- Our inventorΓÇÖs have successfully mammalianized, cloned, and expressed arginine deiminase (ADI) to deplete arginine without increasing either nitric oxide or polyamines. When overexpressed in the brain of tau transgenic mice, ADI significantly decreased tau pathology. Additionally, ADI reduced tau levels in cells that overexpress tau. This novel gene therapy by ADI may serve as a therapeutictarget in reducing aggregation prone proteins such as tau, thus leading to a promising new treatment for age-associated neurodegenerative diseases.
- *Abstract
-
Researchers at the University of South Florida have developed a novel gene therapy for the treatment of age-associated neurodegenerative diseases.
- 国家/地区
- 美国
欲了解更多信息，请点击 这里
